References
- Nilsson-Ehle P, Garfinkel A S, Schotz M C. Lipolytic enzymes and plasma lipoprotein metabolism. Ann Rev Biochem 1980; 49: 667–93
- Kurien V A, Oliver M F. A metabolic cause for arrhythmias during acute myocardial hypoxia. Lancet 1970; i: 813–5
- Craig W A, Suh B. Changes in protein binding during disease. Scand J Infect Dis 1978; 14: 239–44
- Andersson L-O, Barrowcliffe T W, Holmer E, Johnson E A, Sims G EC. Anticoagulant properties of heparin fractionated by affinity chromatography on matrix-bound antithrombin III and by gel filtration. Thromb Res 1976; 9: 575–83
- Persson E, Nordenström J, Nilsson-Ehle P, Hagenfeldt L. Lipolytic and anticoagulant activities of a low molecular weight fragment of heparin. Eur J Clin Invest 1985; 15: 215–20
- Nilsson-Ehle P, Ekman R. Rapid, simple and specific assays for lipoprotein lipase and hepatic lipase. Artery 1977; 3: 194–209
- Kurien V A, Yates P A, Oliver M F. The role of free fatty acids in the production of ventricular arrhythmias after acute coronary occlusion. Eur J Clin Invest 1971; 1: 225–41
- Tansey M JB, Opie L H. Relation between plasma free fatty acids and arrhythmias within the first twelve hours of acute myocardial infarction. Lancet 1983; ii: 419–22
- Smiseth O A, Mjös O D. Haemodynamic and metabolic consequences of elevated plasma free fatty acids during acute ischaemic left ventricular failure in dogs. Scand J Clin Lab Invest 1985; 45: 515–20
- Rudman D, Bixler T J, Del Rio A E. Effect of free fatty acids on binding of drugs to bovine serum albumin by human serum albumin and by rabbit serum. J Pharmacol Exp Therap 1971; 176: 261–72
- Holmer E, Mattsson C, Nilsson S. Anticoagulant and antithrombotic effects of heparin and low molecular weight heparin fragments in rabbits. Thromb Res 1982; 25: 475–85
- Schrader J, Valentin R, Tönnis H-J, Hildebrand U, Stibbe W, Armstrong V, Kandt M, Köstering H, Quellhorst E. Low molecular weight heparin in hemodialysis and hemofiltration patients. Kidney Int 1985; 28: 823–29
- Bergqvist D, Hedner U, Sjörin E, Holmer E. Anticoagulant effects of two types of low molecular weight heparin administered subcutaneously. Thromb Res 1983; 32: 381–91
- Bratt G, Törnebohm E, Lochner D, Bergström K. A human pharmacological study comparing conventional heparin and a low molecular weight heparin fragment. Thromb Hemostas 1985; 53: 208–11